Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Double-blind, Randomized, Placebo-controlled Phase III Confirmatory Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire

NCT03463707 is registered in ClinicalTrials.gov with Ivix LLX as lead sponsor.

NCT NCT03463707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03463707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Double-blind, Randomized, Placebo-controlled Phase III Confirmatory Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire
Lead sponsor
Ivix LLX
Phase
Phase 3
Overall status
Completed
Start date
March 5, 2018
Completion date
January 23, 2019
Enrollment
205 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

female sexual dysfunction, hypoactive sexual desire disorder, sexual desire disorder